Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide in poor ovarian response IVF
NCT03560583Recruiting
- Sponsor
- Barzilai Medical Center
- Start
- May 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in poor ovarian response (POR) comparing Metoclopramide Arm with Placebo Arm (2 arms). Primary endpoint: Number of oocytes. Started May 2021; status: recruiting.
02
Drugs
metoclopramide
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT03560583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03560583.